These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24884966)

  • 21. Detecting Prostate Cancer.
    Brock M; von Bodman C; Palisaar J; Becker W; Martin-Seidel P; Noldus J
    Dtsch Arztebl Int; 2015 Sep; 112(37):605-11. PubMed ID: 26396046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy.
    Hu Y; Ahmed HU; Carter T; Arumainayagam N; Lecornet E; Barzell W; Freeman A; Nevoux P; Hawkes DJ; Villers A; Emberton M; Barratt DC
    BJU Int; 2012 Sep; 110(6):812-20. PubMed ID: 22394583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection.
    Chang JJ; Shinohara K; Hovey RM; Montgomery C; Presti JC
    Urology; 1998 Jul; 52(1):89-93. PubMed ID: 9671876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.
    Park SJ; Miyake H; Hara I; Eto H
    Int J Urol; 2003 Feb; 10(2):68-71. PubMed ID: 12588600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is a sampling transition zone important to increase the detection of prostate cancer in systematic prostatic biopsies?
    Queiroz MR; Falsarella PM; Moreira Valle LG; Cayres Mariotti G; Lemos GC; Alfer Junior W; Garcia RG
    Acta Radiol; 2021 Jun; 62(6):815-820. PubMed ID: 32631078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
    Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
    Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
    Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G
    World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
    Anastasiadis AG; Lichy MP; Nagele U; Kuczyk MA; Merseburger AS; Hennenlotter J; Corvin S; Sievert KD; Claussen CD; Stenzl A; Schlemmer HP
    Eur Urol; 2006 Oct; 50(4):738-48; discussion 748-9. PubMed ID: 16630688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study.
    Naughton CK; Smith DS; Humphrey PA; Catalona WJ; Keetch DW
    Urology; 1998 Nov; 52(5):808-13. PubMed ID: 9801104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the diagnostic yield of prostate needle biopsies affected by prostate volume?
    Leibovici D; Shilo Y; Raz O; Stav K; Sandbank J; Segal M; Zisman A
    Urol Oncol; 2013 Oct; 31(7):1003-5. PubMed ID: 21924650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.
    Mowatt G; Scotland G; Boachie C; Cruickshank M; Ford JA; Fraser C; Kurban L; Lam TB; Padhani AR; Royle J; Scheenen TW; Tassie E
    Health Technol Assess; 2013 May; 17(20):vii-xix, 1-281. PubMed ID: 23697373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies.
    Nafie S; Pal RP; Dormer JP; Khan MA
    World J Urol; 2014 Aug; 32(4):971-5. PubMed ID: 24337167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies.
    Pryor MB; Schellhammer PF
    Clin Prostate Cancer; 2002 Dec; 1(3):172-6. PubMed ID: 15046692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transitional zone and anterior peripheral zone of the prostate. A correlation of small-volume cancer in the biopsy cores and high psa with positive anterior margins in radical prostatectomy specimens.
    Mai KT; Moazin M; Morash C; Collins JP
    Urol Int; 2001; 66(4):191-6. PubMed ID: 11385304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of prostate size on cancer detection.
    Uzzo RG; Wei JT; Waldbaum RS; Perlmutter AP; Byrne JC; Vaughan ED
    Urology; 1995 Dec; 46(6):831-6. PubMed ID: 7502425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
    Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
    Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies.
    Durmuş T; Reichelt U; Huppertz A; Hamm B; Beyersdorff D; Franiel T
    Diagn Interv Radiol; 2013; 19(5):411-7. PubMed ID: 23886937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection rate of anterior prostate cancer in 226 patients submitted to initial and repeat transperineal biopsy.
    Pepe P; Dibenedetto G; Pennisi M; Fraggetta F; Colecchia M; Aragona F
    Urol Int; 2014; 93(2):189-92. PubMed ID: 24776888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.
    Scattoni V; Roscigno M; Raber M; Montorsi F; Da Pozzo L; Guazzoni G; Freschi M; Rigatti P
    Eur Urol; 2003 Oct; 44(4):407-14. PubMed ID: 14499673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.